Deep Medicine (NASDAQ:DMAQ) announced this afternoon that its shareholders approved its combination with golf simulator company TruGolf during a special meeting on January 19.
At the meeting, holders of 3,952,979 shares of DMAQ’s Class A common stock were present, constituting a quorum. The deal was overwhelmingly approved as holders of 3,933,438 shares voted in favor of the proposal, while holders of 18,838 shares pushed back against the combination.
In connection with the vote, shareholders of 378,744 DMAQ’s public shares opted to redeem their shares. DMAQ shareholders have redeemed an aggregate of 98.5% of the trust thus far (including prior votes), leaving the SPAC with $2,254,230 and 196,020 shares remaining.
The parties did not provide a timeline for the closing of the deal, but expect to complete it upon satisfaction or waiver of all the closing conditions, including approval to list on The Nasdaq. Upon closing, the combined company is expected to trade on the Nasdaq under the symbol “TRUG”.
The SPAC also has a minimum cash condition of at least $10 million, This amount is calculated after accounting for any redemptions and payment of amounts owed to DMAQ’s sponsor and its affiliates but before settling any unpaid expenses or liabilities, with a cap of $1.6 million.
Deep Medicine announced its $125 million deal with TruGolf in April 2023. It previously planned to combine with Chinese carmaker Chijet, but the deal was terminated in September 2022. Centerville, Utah-based TruGolf manufactures advanced golf simulators and launch monitors for both home entertainment and commercial uses.
At the SPAC of Dawn Two new SPACs priced their IPOs yesterday, showing that SPACs at least are not entirely spooked by the markets continued downturn. Futures continue to be beet red heading into the second day of the week, particularly for the SPAC-favorite exchange Nasdaq. SPACs have the potential to shine in this environment,...
An In-Depth Look at SPAC Activity Through the First Quarter 2025 Below is a summary of the Q1-2025 SPAC market. If you’d like a pdf copy, you can access the link HERE. While SPAC IPO issuance has continued to climb modestly in Q1, it’s doing so at a more sustainable and disciplined pace compared to...
Siddhi Acquisition Corp. (NASDAQ:SDHIU) announced the pricing of its upsized $240 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “SDHIU”, Tuesday, April 1, 2025. The new SPAC plans to mount a broad search for a target company leveraging its internal network of relationships. Siddhi is to be...
UY Scuti Acquisition Corp. (NASDAQ:UYSCU) announced the pricing of its $50 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “UYSCU”, Tuesday, April 1, 2025. The new SPAC aims to combine with a target company in Asia, but it does not have a specific preference on industry or...
April is set to be a less-eventful month for SPAC dealmakers seeing their shares unlocked, but the activity does start already tomorrow. The sponsor of Excelfin is set to see its promote shares in Baird Medical (NASDAQ:BDMD) come available to trade on April 1. It is one of just two sponsors being released this month...